<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36434067</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.</ArticleTitle><Pagination><StartPage>1293</StartPage><MedlinePgn>1293</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1293</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-022-04252-5</ELocationID><Abstract><AbstractText>Strategies to prevent the recurrence of poliovirus (PV) after eradication may utilise non-infectious, recombinant virus-like particle (VLP) vaccines. Despite clear advantages over inactivated or attenuated virus vaccines, instability of VLPs can compromise their immunogenicity. Glutathione (GSH), an important cellular reducing agent, is a crucial co-factor for the morphogenesis of enteroviruses, including PV. We report cryo-EM structures of GSH bound to PV serotype 3 VLPs showing that it can enhance particle stability. GSH binds the positively charged pocket at the interprotomer interface shown recently to bind GSH in enterovirus F3 and putative antiviral benzene sulphonamide compounds in other enteroviruses. We show, using high-resolution cryo-EM, the binding of a benzene sulphonamide compound with a PV serotype 2 VLP, consistent with antiviral activity through over-stabilizing the interprotomer pocket, preventing the capsid rearrangements necessary for viral infection. Collectively, these results suggest GSH or an analogous tight-binding antiviral offers the potential for stabilizing VLP vaccines.</AbstractText><CopyrightInformation>© 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bahar</LastName><ForeName>Mohammad W</ForeName><Initials>MW</Initials><Identifier Source="ORCID">0000-0002-2350-2682</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK. mohammad.bahar@strubi.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasta</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Magnetic Resonance Center CERM, University of Florence, Via Luigi Sacconi 6, 50019, Sesto Fiorentino, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019, Sesto Fiorentino, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The National Institute for Biological Standards and Control, Potters Bar, EN6 3QG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherry</LastName><ForeName>Lee</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4367-772X</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grehan</LastName><ForeName>Keith</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3976-756X</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta</LastName><ForeName>Claudine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Pirbright Institute, Pirbright, Surrey, GU24 0NF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macadam</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-8687-1573</Identifier><AffiliationInfo><Affiliation>The National Institute for Biological Standards and Control, Potters Bar, EN6 3QG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stonehouse</LastName><ForeName>Nicola J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0003-1146-5519</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowlands</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-4742-9272</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fry</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><Identifier Source="ORCID">0000-0001-9754-5303</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>David I</ForeName><Initials>DI</Initials><Identifier Source="ORCID">0000-0002-3426-4210</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK. dave.stuart@strubi.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK. dave.stuart@strubi.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>093305/Z/10/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N00065X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_17137</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>060208/Z/00/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V001329/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>101122/Z/13/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RG.IMCB.I8-TSA-083</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>203141/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>J64922108F</RegistryNumber><NameOfSubstance UI="D001554">Benzene</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058425">Vaccines, Virus-Like Particle</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>GAN16C9B8O</RegistryNumber><NameOfSubstance UI="D005978">Glutathione</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Commun Biol. 2022 Dec 23;5(1):1413. doi: 10.1038/s42003-022-04378-6</RefSource><PMID Version="1">36564504</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001554" MajorTopicYN="N">Benzene</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058425" MajorTopicYN="Y">Vaccines, Virus-Like Particle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36434067</ArticleId><ArticleId IdType="pmc">PMC9700776</ArticleId><ArticleId IdType="doi">10.1038/s42003-022-04252-5</ArticleId><ArticleId IdType="pii">10.1038/s42003-022-04252-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bailey ES, Fieldhouse JK, Choi JY, Gray GC. A mini review of the zoonotic threat potential of influenza viruses, coronaviruses, adenoviruses, and enteroviruses. Front. Public Health. 2018;6:104. doi: 10.3389/fpubh.2018.00104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2018.00104</ArticleId><ArticleId IdType="pmc">PMC5900445</ArticleId><ArticleId IdType="pubmed">29686984</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuthill TJ, Groppelli E, Hogle JM, Rowlands DJ. Picornaviruses. Curr. Top. Microbiol. Immunol. 2010;343:43–89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3018333</ArticleId><ArticleId IdType="pubmed">20397067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Kung YA, Shih SR. Antivirals and vaccines for Enterovirus A71. J. Biomed. Sci. 2019;26:65. doi: 10.1186/s12929-019-0560-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0560-7</ArticleId><ArticleId IdType="pmc">PMC6720414</ArticleId><ArticleId IdType="pubmed">31481071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay AS, Garon J, Seib K, Orenstein WA. Polio vaccination: past, present and future. Future Microbiol. 2015;10:791–808. doi: 10.2217/fmb.15.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.19</ArticleId><ArticleId IdType="pubmed">25824845</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TJ, et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 1986;233:1286–1293. doi: 10.1126/science.3018924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3018924</ArticleId><ArticleId IdType="pubmed">3018924</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox MP, Otto MJ, McKinlay MA. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob. Agents Chemother. 1986;30:110–116. doi: 10.1128/AAC.30.1.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.30.1.110</ArticleId><ArticleId IdType="pmc">PMC176446</ArticleId><ArticleId IdType="pubmed">3019232</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 2012;19:424–429. doi: 10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang SK, Danthi P, Chow M, Hogle JM. Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects. J. Mol. Biol. 2000;296:335–340. doi: 10.1006/jmbi.1999.3483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.3483</ArticleId><ArticleId IdType="pubmed">10669591</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma AM, et al. Potential use of antiviral agents in polio eradication. Emerg. Infect. Dis. 2008;14:545–551. doi: 10.3201/eid1404.070439.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1404.070439</ArticleId><ArticleId IdType="pmc">PMC2570929</ArticleId><ArticleId IdType="pubmed">18394270</ArticleId></ArticleIdList></Reference><Reference><Citation>Global polio eradication initiative. Polio now (August 2022).</Citation></Reference><Reference><Citation>Ansardi DC, Porter DC, Morrow CD. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J. Virol. 1991;65:2088–2092. doi: 10.1128/jvi.65.4.2088-2092.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.65.4.2088-2092.1991</ArticleId><ArticleId IdType="pmc">PMC240068</ArticleId><ArticleId IdType="pubmed">1848318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson M, Wood DJ, Minor PD. Antigenic structure of poliovirus in inactivated vaccines. J. Gen. Virol. 1993;74:685–690. doi: 10.1099/0022-1317-74-4-685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-74-4-685</ArticleId><ArticleId IdType="pubmed">7682250</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavappa R, et al. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci. 1994;3:1651–1669. doi: 10.1002/pro.5560031005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.5560031005</ArticleId><ArticleId IdType="pmc">PMC2142606</ArticleId><ArticleId IdType="pubmed">7849583</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox H, Knowlson S, Minor PD, Macadam AJ. Genetically thermo-stabilised, immunogenic poliovirus empty capsids; a strategy for non-replicating vaccines. PLoS Pathog. 2017;13:e1006117. doi: 10.1371/journal.ppat.1006117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006117</ArticleId><ArticleId IdType="pmc">PMC5245777</ArticleId><ArticleId IdType="pubmed">28103317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahar MW, et al. Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines. NPJ Vaccines. 2021;6:5. doi: 10.1038/s41541-020-00267-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-020-00267-3</ArticleId><ArticleId IdType="pmc">PMC7794334</ArticleId><ArticleId IdType="pubmed">33420068</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherry, L. et al. Comparative molecular biology approaches for the production of poliovirus virus-like particles using Pichia pastoris. mSphere10.1128/mSphere.00838-19 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7067596</ArticleId><ArticleId IdType="pubmed">32161150</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, et al. Virus-like particle vaccines for poliovirus types 1, 2, and 3 with enhanced thermostability expressed in insect cells. Vaccine. 2019;37:2340–2347. doi: 10.1016/j.vaccine.2019.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.03.031</ArticleId><ArticleId IdType="pubmed">30922699</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsian J, et al. Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nat. Commun. 2017;8:245. doi: 10.1038/s41467-017-00090-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00090-w</ArticleId><ArticleId IdType="pmc">PMC5557999</ArticleId><ArticleId IdType="pubmed">28811473</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutter RW, Modlin JF, Zaffran M. Completing polio eradication: the case for antiviral drugs. J. Infect. Dis. 2017;215:333–334.</Citation><ArticleIdList><ArticleId IdType="pubmed">27932609</ArticleId></ArticleIdList></Reference><Reference><Citation>Collett MS, Neyts J, Modlin JF. A case for developing antiviral drugs against polio. Antivir. Res. 2008;79:179–187. doi: 10.1016/j.antiviral.2008.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2008.04.002</ArticleId><ArticleId IdType="pubmed">18513807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mari M, Morales A, Colell A, Garcia-Ruiz C, Fernandez-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid. Redox Signal. 2009;11:2685–2700. doi: 10.1089/ars.2009.2695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2695</ArticleId><ArticleId IdType="pmc">PMC2821140</ArticleId><ArticleId IdType="pubmed">19558212</ArticleId></ArticleIdList></Reference><Reference><Citation>Meister A, Anderson ME. Glutathione. Annu Rev. Biochem. 1983;52:711–760. doi: 10.1146/annurev.bi.52.070183.003431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bi.52.070183.003431</ArticleId><ArticleId IdType="pubmed">6137189</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Z, et al. Isochlorogenic acid C prevents enterovirus 71 infection via modulating redox homeostasis of glutathione. Sci. Rep. 2017;7:16278. doi: 10.1038/s41598-017-16446-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-16446-7</ArticleId><ArticleId IdType="pmc">PMC5701158</ArticleId><ArticleId IdType="pubmed">29176678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma HC, et al. An interaction between glutathione and the capsid is required for the morphogenesis of C-cluster enteroviruses. PLoS Pathog. 2014;10:e1004052. doi: 10.1371/journal.ppat.1004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004052</ArticleId><ArticleId IdType="pmc">PMC3983063</ArticleId><ArticleId IdType="pubmed">24722315</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikami T, Satoh N, Hatayama I, Nakane A. Buthionine sulfoximine inhibits cytopathic effect and apoptosis induced by infection with human echovirus 9. Arch. Virol. 2004;149:1117–1128. doi: 10.1007/s00705-003-0283-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-003-0283-6</ArticleId><ArticleId IdType="pubmed">15168199</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut HJ, et al. Binding of glutathione to enterovirus capsids is essential for virion morphogenesis. PLoS Pathog. 2014;10:e1004039. doi: 10.1371/journal.ppat.1004039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004039</ArticleId><ArticleId IdType="pmc">PMC3983060</ArticleId><ArticleId IdType="pubmed">24722756</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AD, Dawson H. Glutathione is required for efficient production of infectious picornavirus virions. Virology. 2006;353:258–267. doi: 10.1016/j.virol.2006.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.06.012</ArticleId><ArticleId IdType="pubmed">16860836</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi R, et al. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS Biol. 2019;17:e3000281. doi: 10.1371/journal.pbio.3000281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000281</ArticleId><ArticleId IdType="pmc">PMC6559632</ArticleId><ArticleId IdType="pubmed">31185007</ArticleId></ArticleIdList></Reference><Reference><Citation>Flatt JW, Domanska A, Seppala AL, Butcher SJ. Identification of a conserved virion-stabilizing network inside the interprotomer pocket of enteroviruses. Commun. Biol. 2021;4:250. doi: 10.1038/s42003-021-01779-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01779-x</ArticleId><ArticleId IdType="pmc">PMC7910612</ArticleId><ArticleId IdType="pubmed">33637854</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyvesteyn HME, Ren J, Walter TS, Fry EE, Stuart DI. Glutathione facilitates enterovirus assembly by binding at a druggable pocket. Commun. Biol. 2020;3:9. doi: 10.1038/s42003-019-0722-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-019-0722-x</ArticleId><ArticleId IdType="pmc">PMC6941975</ArticleId><ArticleId IdType="pubmed">31909201</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi R, Delang L, Neyts J. Glutathione is a highly efficient thermostabilizer of poliovirus Sabin strains. Vaccine. 2017;35:1370–1372. doi: 10.1016/j.vaccine.2017.01.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.01.070</ArticleId><ArticleId IdType="pubmed">28189401</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SH. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 2012;180:519–530. doi: 10.1016/j.jsb.2012.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2012.09.006</ArticleId><ArticleId IdType="pmc">PMC3690530</ArticleId><ArticleId IdType="pubmed">23000701</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherry L, et al. Production and characterisation of stabilised PV-3 virus-like particles using Pichia pastoris. Viruses. 2022;14:2159. doi: 10.3390/v14102159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102159</ArticleId><ArticleId IdType="pmc">PMC9611624</ArticleId><ArticleId IdType="pubmed">36298714</ArticleId></ArticleIdList></Reference><Reference><Citation>Filman DJ, et al. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 1989;8:1567–1579. doi: 10.1002/j.1460-2075.1989.tb03541.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1989.tb03541.x</ArticleId><ArticleId IdType="pmc">PMC400988</ArticleId><ArticleId IdType="pubmed">2548847</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife10.7554/eLife.42166 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6250425</ArticleId><ArticleId IdType="pubmed">30412051</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah PNM, et al. Cryo-EM structures reveal two distinct conformational states in a picornavirus cell entry intermediate. PLoS Pathog. 2020;16:e1008920. doi: 10.1371/journal.ppat.1008920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008920</ArticleId><ArticleId IdType="pmc">PMC7549760</ArticleId><ArticleId IdType="pubmed">32997730</ArticleId></ArticleIdList></Reference><Reference><Citation>Swartz AR, Shieh Y, Gulasarian A, Olson JW, Rustandi RR. Binding of Coxsackievirus A21 procapsids to immobilized glutathione depends on cell culture conditions during infection. Virology. 2022;573:167–175. doi: 10.1016/j.virol.2022.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2022.06.013</ArticleId><ArticleId IdType="pubmed">35834888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J, Nakane T, Scheres SHW. Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1. IUCrJ. 2020;7:253–267. doi: 10.1107/S2052252520000081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2052252520000081</ArticleId><ArticleId IdType="pmc">PMC7055373</ArticleId><ArticleId IdType="pubmed">32148853</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331–332. doi: 10.1038/nmeth.4193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4193</ArticleId><ArticleId IdType="pmc">PMC5494038</ArticleId><ArticleId IdType="pubmed">28250466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A, Grigorieff N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216–221. doi: 10.1016/j.jsb.2015.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner T, et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. 2019;2:218. doi: 10.1038/s42003-019-0437-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-019-0437-z</ArticleId><ArticleId IdType="pmc">PMC6584505</ArticleId><ArticleId IdType="pubmed">31240256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivioja T, Ravantti J, Verkhovsky A, Ukkonen E, Bamford D. Local average intensity-based method for identifying spherical particles in electron micrographs. J. Struct. Biol. 2000;131:126–134. doi: 10.1006/jsbi.2000.4279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsbi.2000.4279</ArticleId><ArticleId IdType="pubmed">11042083</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Rosa-Trevin JM, et al. Scipion: a software framework toward integration, reproducibility and validation in 3D electron microscopy. J. Struct. Biol. 2016;195:93–99. doi: 10.1016/j.jsb.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2016.04.010</ArticleId><ArticleId IdType="pubmed">27108186</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SH, Chen S. Prevention of overfitting in cryo-EM structure determination. Nat. Methods. 2012;9:853–854. doi: 10.1038/nmeth.2115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2115</ArticleId><ArticleId IdType="pmc">PMC4912033</ArticleId><ArticleId IdType="pubmed">22842542</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, et al. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanal A, Lohkamp B, Emsley P. Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data. Protein Sci. 2020;29:1069–1078. doi: 10.1002/pro.3791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3791</ArticleId><ArticleId IdType="pmc">PMC7096722</ArticleId><ArticleId IdType="pubmed">31730249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lentz KN, et al. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure. 1997;5:961–978. doi: 10.1016/S0969-2126(97)00249-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(97)00249-9</ArticleId><ArticleId IdType="pubmed">9261087</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebschner D, et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D. Struct. Biol. 2019;75:861–877. doi: 10.1107/S2059798319011471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798319011471</ArticleId><ArticleId IdType="pmc">PMC6778852</ArticleId><ArticleId IdType="pubmed">31588918</ArticleId></ArticleIdList></Reference><Reference><Citation>Afonine PV, et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D. Struct. Biol. 2018;74:531–544. doi: 10.1107/S2059798318006551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798318006551</ArticleId><ArticleId IdType="pmc">PMC6096492</ArticleId><ArticleId IdType="pubmed">29872004</ArticleId></ArticleIdList></Reference><Reference><Citation>Smart, O. S. et al. Grade, version 1.2.20. Cambridge, United Kingdom, Global Phasing Ltd., https://www.globalphasing.com (2011).</Citation></Reference><Reference><Citation>Williams CJ, et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 2018;27:293–315. doi: 10.1002/pro.3330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3330</ArticleId><ArticleId IdType="pmc">PMC5734394</ArticleId><ArticleId IdType="pubmed">29067766</ArticleId></ArticleIdList></Reference><Reference><Citation>Barad BA, et al. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nat. Methods. 2015;12:943–946. doi: 10.1038/nmeth.3541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3541</ArticleId><ArticleId IdType="pmc">PMC4589481</ArticleId><ArticleId IdType="pubmed">26280328</ArticleId></ArticleIdList></Reference><Reference><Citation>Prisant MG, Williams CJ, Chen VB, Richardson JS, Richardson DC. New tools in MolProbity validation: CaBLAM for CryoEM backbone, UnDowser to rethink “waters,” and NGL Viewer to recapture online 3D graphics. Protein Sci. 2020;29:315–329. doi: 10.1002/pro.3786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3786</ArticleId><ArticleId IdType="pmc">PMC6933861</ArticleId><ArticleId IdType="pubmed">31724275</ArticleId></ArticleIdList></Reference><Reference><Citation>Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007;372:774–797. doi: 10.1016/j.jmb.2007.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.05.022</ArticleId><ArticleId IdType="pubmed">17681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart DI, Levine M, Muirhead H, Stammers DK. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. J. Mol. Biol. 1979;134:109–142. doi: 10.1016/0022-2836(79)90416-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(79)90416-9</ArticleId><ArticleId IdType="pubmed">537059</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamford DH, Grimes JM, Stuart DI. What does structure tell us about virus evolution. Curr. Opin. Struct. Biol. 2005;15:655–663. doi: 10.1016/j.sbi.2005.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2005.10.012</ArticleId><ArticleId IdType="pubmed">16271469</ArticleId></ArticleIdList></Reference><Reference><Citation>Riffel N, et al. Atomic resolution structure of Moloney murine leukemia virus matrix protein and its relationship to other retroviral matrix proteins. Structure. 2002;10:1627–1636. doi: 10.1016/S0969-2126(02)00896-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(02)00896-1</ArticleId><ArticleId IdType="pubmed">12467570</ArticleId></ArticleIdList></Reference><Reference><Citation>Felsenstein, J. PHYLIP (Phylogeny Inference Package) version 3.6. Distributed by the author. http://evolution.genetics.washington.edu/phylip.html (2004).</Citation></Reference><Reference><Citation>Sievers F, Higgins DG. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 2018;27:135–145. doi: 10.1002/pro.3290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3290</ArticleId><ArticleId IdType="pmc">PMC5734385</ArticleId><ArticleId IdType="pubmed">28884485</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 2014;42:W320–W324. doi: 10.1093/nar/gku316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku316</ArticleId><ArticleId IdType="pmc">PMC4086106</ArticleId><ArticleId IdType="pubmed">24753421</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 2011;51:2778–2786. doi: 10.1021/ci200227u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci200227u</ArticleId><ArticleId IdType="pubmed">21919503</ArticleId></ArticleIdList></Reference><Reference><Citation>The PyMOL Molecular Graphics System version 2.0 (Schrödinger, LLC, 2015).</Citation></Reference><Reference><Citation>Pettersen EF, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70–82. doi: 10.1002/pro.3943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3943</ArticleId><ArticleId IdType="pmc">PMC7737788</ArticleId><ArticleId IdType="pubmed">32881101</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>